![](https://d3ilqtpdwi981i.cloudfront.net/_EHQyl2JDU90sKPhyzEe20KEYg4=/0x0:721x935/425x550/smart/https://bepress-attached-resources.s3.amazonaws.com/uploads/fe/10/0d/fe100d09-d993-497f-9ef0-a65cf88e3222/CMAR2.png)
Article
Addressing Physician Barriers to Administering Cyclin-dependent Kinases 4 and 6 Inhibitors in First-line Treatment of Hormone Receptor-positive, Human Epidermal Growth Factor Receptor 2-negative Advanced Breast cancer
Cancer Management and Research
(2019)
Disciplines
Publication Date
2019
Citation Information
Reshma Mahtani and Charles L. Vogel. "Addressing Physician Barriers to Administering Cyclin-dependent Kinases 4 and 6 Inhibitors in First-line Treatment of Hormone Receptor-positive, Human Epidermal Growth Factor Receptor 2-negative Advanced Breast cancer" Cancer Management and Research Vol. 11 (2019) p. 513 - 524 Available at: http://works.bepress.com/reshma-mahtani/87/